simulations-plus.com (SLP): Price/Earnings to Growth Multiple
Simulations Plus, Inc. (SLP) implements advanced digital modeling methods, reducing R&D costs through its GastroPlus software. The current PEG ratio reflects the market valuation of the asset, with the indicator standing at 0.00. Market capitalization is driven by demand from regulators and pharma behemoths to accelerate drug time-to-market. Meanwhile, financial stability is based on steady licensing, despite a dependence on biotech sector budgets.
Simulations Plus, Inc. (SLP) - metric breakdowns and financial figures
- price and consensus price forecast:
- stock exchange capitalization data:
- book value of equity indicators:
- business debt structure and liquidity details:
Total Debt to Capital Simulations Plus, Inc.|SLP - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio simulations-plus.com|SLP - Company Aggregate Debts|Debts to Net Assets Simulations Plus Corp|SLP - Company Long-Term Debt|Short-Term Debt Simulations Plus|Immediate Liquidity Ratio simulations-plus.com
- company profitability and valuation multiples indicators:
SLP - Company Net Income|Company Profit Forecast Simulations Plus, Inc.|SLP - Price to Earnings Ratio|Future Price to Earnings Multiple Simulations Plus Inc.|SLP - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Simulations Plus Corp|SLP - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Simulations Plus|SLP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth simulations-plus.com|SLP - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Simulations Plus, Inc.
General company analysis:SLP, Simulations Plus Inc
Professional managers utilize the PEG ratio to compare the market value of earnings against their expansion rate, where a value below one signals that an asset is undervalued relative to its potential. For Simulations Plus (SLP), which optimizes costs for pharma behemoths through simulation software, this logic enables an assessment of business scaling efficiency, a trend captured by the price-to-earnings ratio relative to growth rates.
Competitors of Simulations Plus, Inc.
Growth-Adjusted Market Cap to Net Income Veeva Systems|Price/Earnings to Growth Ratio Doximity Corp DOCS|HQY - Price/Earnings to Growth Multiple|WAY: Price/Earnings to Growth Multiple|CRVL - PEG Multiple|Privia Health (PRVA) - Price/Earnings to Growth Ratio|HURN (Huron Consulting Group Inc.) - Price/Earnings to Growth Ratio|CERT (Certara Corp) - PEG Multiple|PEG Multiple Omnicell Health|Price/Earnings to Growth Multiple GDRX (GoodRx Holdings, Inc.)|Company Value to Earnings Growth Ratio SDGR|PEG Multiple PHR (Phreesia)|Growth-Adjusted Market Cap to Net Income Omada Health, Inc. (OMDA)|EVH - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate HealthStream Learning|Definitive Healthcare (DH) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio CCSI|Price/Earnings to Growth Ratio agilon health|Absci Corp (ABSI) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple SY (SoYoung)|NRC (National Research Corp.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Spok Holdings, Inc. SPOK|OPRX (optimizerx.com) - Market Cap to Earnings and Growth Ratio|TBRG - Price/Earnings to Growth Ratio|SOPH: Price/Earnings to Growth Ratio|HCAT (Health Catalyst, Inc) - Price/Earnings to Growth Multiple|CareCloud (CCLD) - PEG Multiple|Price/Earnings to Growth Ratio Research Solutions|DLH Holdings Corp (DLHC) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple ONMD (OneMedNet Corporation)|SCNX (Scienture Holdings) - Growth-Adjusted Payback Ratio|PEG Multiple HCTI (Healthcare Triangle Corp)|Growth-Adjusted Market Cap to Net Income iSpecimen Inc (ISPC)|BFRG - Price/Earnings to Growth Ratio|WORX (scworx.com) - Growth-Adjusted P/E Ratio|MSPR: PEG Multiple|Price/Earnings to Growth Multiple iCoreConnect|Price/Earnings to Growth Multiple MEDS|Orgenesis Corporation (ORGS) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio R1 RCM Inc. (RCM)|Growth-Adjusted Market Cap to Net Income sharecare.com|Price/Earnings to Growth Ratio Streamline Health STRM|Syra Health Corp - Price/Earnings to Growth Ratio|AMEH - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio MODN|NXGN: PEG Multiple
